The Inhibition of Endostatin on Tumor Growth and Metastasis of Lung Adenocarcinoma LA795 in Mice
- VernacularTitle:内皮抑素对小鼠肺腺癌LA795生长和转移抑制作用的初步研究
- Author:
Deling LIU
;
Jinxu WEN
;
Wancheng TONG
;
Liheng BEN
- Publication Type:Journal Article
- Keywords:
angiogenesis inhibitor;
endostatin;
angiostatin;
purification;
lung adenocarcinoma;
T739 mice
- From:
Chinese Journal of Cancer Biotherapy
2000;7(4):269-272
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To evaluate the inhibition of human endostatin on tumor growth and metastasis of lung adenocarcinoma LA795 in mice. Methods: Recombinant human endostatin was purified from pCX expressed endostatin clones. Plasminogen was purified from outdated human plasma by affinity chromatography, and human angiostatin was produced from human plasminogen digested by elastase and purified by affinity chromatography. LA795 cells were inoculated subcutaneously into the dorsa of T739 mice, and the mice were randomized into 3 groups. From the 1Oth day, the first group was given 20 mg/kg of recombinant human endostatin s.c. qd, the second was treated daily s. c. of 7.5 mg/kg of human angiostatin, and the third group received daily s.c. with equal volumes of PBS for 14 days. Volumes of the subcutaneous tumors, lung weights, the number of lung surface metastases and mice life span were observed. The results were analyzed by q-test. Results: The tumor volumes of both the 1 st and the 2nd groups increased slowly. From the 8th day after being treated, the tumor volumes were decreasing. However, in the 3rd group, the tumor volumes increased continuously. The lung weight and the number of lung surface metastases of the 1st and 2nd groups were less than that of the 3rd group. The average survival periods of the 1st and 2nd groups were longer than that of the 3rd group. Conclusion: Human endostatin and angiostatin have strong inhibitory effects both on growth of primary tumor and metastasis of lung adenocarcinoma LA795, and prolongs the survival period of the tumor-bearing mice.
